Submit Manuscript

International Journal of Pharmacology

Year: 2010 | Volume: 6 | Issue: 4 | Page No.: 456-463
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend

Total views 1535

Search

Authors

E.Y. Sukandar

H. Permana

I.K. Adnyana

J.I. Sigit

R.A. Ilyas

P. Hasimun

D. Mardiyah

Keywords

Research Article

Clinical Study of Turmeric (Curcuma longa L.) and Garlic (Allium sativum L.) Extracts as Antihyperglycemic and Antihyperlipidemic Agent in Type-2 Diabetes-Dyslipidemia Patients

E.Y. Sukandar, H. Permana, I.K. Adnyana, J.I. Sigit, R.A. Ilyas, P. Hasimun and D. Mardiyah
Turmeric (Curcuma longa L.) and garlic (Allium sativum Lin.) are known as traditional drugs that can cure several diseases such as dyslipidemia and diabetes. Many studies on individual usages of garlic and turmeric have been done previously. Present preclinical study showed that combination of both substances gave a better result compared to their individual usage. This research was aimed to evaluate the efficacy and safety of turmeric and garlic extracts combination as antihyperglycemic and antihyperlipidemic agents for type-2 diabetes-dyslipidemia. Three doses were evaluated: 1.2, 1.6 and 2.4 g, daily. It was found that the garlic-curcuma combination could reduce plasma glucose level and HbA1C as well as improve the lipid profile. Among those 3 dosages, the dose of 2.4 g decreased fasting glucose level, 2 h postprandial glucose level, HbA1C, total cholesterol, low density lipoprotein, triglyceride and body mass index more than the two other dosages. This dose level also increased high density lipoprotein higher than the other two dosages. There was no significant adverse event observed during the study. The treatment also showed no side effect on kidney and liver functions as well as the blood composition of all subjects.
PDF Fulltext XML References Citation

How to cite this article

E.Y. Sukandar, H. Permana, I.K. Adnyana, J.I. Sigit, R.A. Ilyas, P. Hasimun and D. Mardiyah, 2010. Clinical Study of Turmeric (Curcuma longa L.) and Garlic (Allium sativum L.) Extracts as Antihyperglycemic and Antihyperlipidemic Agent in Type-2 Diabetes-Dyslipidemia Patients. International Journal of Pharmacology, 6: 456-463.

DOI: 10.3923/ijp.2010.456.463

URL: https://scialert.net/abstract/?doi=ijp.2010.456.463

Related Articles

Prevention of Hypertension and Arterial Stiffness by Combination of Centella asiatica and Curcuma longa in Rats
Safety of Garlic (Allium Sativum) and Turmeric (Curcuma domestica) Extract in Comparison with Simvastatin on Improving Lipid Profile in Dyslipidemia Patients
Antihypercholesterolemic Effect of Combination of Guazuma ulmifolia Lamk. Leaves and Curcuma xanthorrhiza Roxb. Rhizomes Extract in Wistar Rats
Influence of Storage on the Volatile Oil Content of Curcuma Rhizome
Plant as a Source of Natural Antiviral Agents
Oral Administration of Extract from Curcuma longa Lowers Blood Glucose and Attenuates Alloxan-Induced Hyperlipidemia in Diabetic Rabbits
Lipid Profile of Chicken (Gallus domesticus) in Response to Dietary Supplementation of Garlic (Allium sativum)

Leave a Comment

Your email address will not be published. Required fields are marked *